AC Immune (ACIU) Change in Account Payables (2017 - 2025)
AC Immune (ACIU) reported Change in Account Payables of $414137.2 for Q4 2025, down 70.79% year-over-year from $1.4 million in Q4 2024, and up 128.44% on a QoQ basis from -$1.5 million in Q3 2025.
AC Immune (ACIU) has 9 years of Change in Account Payables data on file, last reported at $414137.2 in Q4 2025.
- Quarterly Change in Account Payables fell 70.79% year-over-year to $414137.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$713779.1 (down 161.01% YoY) and the FY2025 annual result came in at -$714028.1, down 164.02% from the prior year.
- Change in Account Payables climbed to $414137.2 in Q4 2025 per ACIU's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.0 million in Q4 2021 and bottomed at -$2.0 million in Q1 2021.
- The 5-year median for Change in Account Payables is $64889.3 (2023), against an average of -$123.93.
- The widest annual swing landed in 2022, when Change in Account Payables soared 1678.46%; it then tumbled 6541.05% in 2025.
- Tracing ACIU's Change in Account Payables over 5 years: stood at $2.0 million in 2021, then slumped by 137.01% to -$727653.4 in 2022, then jumped by 131.45% to $228853.0 in 2023, then surged by 519.51% to $1.4 million in 2024, then sank by 70.79% to $414137.2 in 2025.
- Per Business Quant, the three latest ACIU Change in Account Payables figures stand at $414137.2 (Q4 2025), -$1.5 million (Q3 2025), and $748891.9 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 414,137.20 |
| Dec 31, 2025 | 414,137.20 |
| Sep 30, 2025 | -1.46 Mn |
| Sep 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | 748,891.94 |
| Jun 30, 2025 | 748,891.94 |
| Mar 31, 2025 | -420,430.70 |
| Mar 31, 2025 | -420,430.70 |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -21,929.94 |
| Sep 30, 2024 | -21,929.94 |
| Jun 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | -1.55 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 228,852.96 |
| Dec 31, 2023 | 228,852.96 |
| Sep 30, 2023 | 151,708.44 |
| Sep 30, 2023 | 151,708.44 |
| Jun 30, 2023 | 250,239.50 |
| Jun 30, 2023 | 250,239.50 |
| Mar 31, 2023 | 224,881.82 |
| Mar 31, 2023 | 224,881.82 |
| Dec 31, 2022 | -727,653.36 |
| Dec 31, 2022 | -727,653.36 |
| Sep 30, 2022 | 1.25 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | -94,484.66 |
| Jun 30, 2022 | -94,484.66 |
| Mar 31, 2022 | -1.62 Mn |
| Mar 31, 2022 | -1.62 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | -79,506.43 |
| Sep 30, 2021 | -79,506.43 |
| Jun 30, 2021 | -28,512.82 |
| Jun 30, 2021 | -28,512.82 |
| Mar 31, 2021 | -1.99 Mn |
| Mar 31, 2021 | -1.99 Mn |
| Dec 31, 2020 | 1.36 Mn |
| Dec 31, 2020 | 1.36 Mn |
| Sep 30, 2020 | -449,755.32 |
| Sep 30, 2020 | -449,755.32 |
| Jun 30, 2020 | 744,111.12 |
| Jun 30, 2020 | 744,111.12 |
| Mar 31, 2020 | 661,661.82 |
| Mar 31, 2020 | 661,661.82 |
| Dec 31, 2019 | 172,775.60 |
| Dec 31, 2019 | 172,775.60 |
| Sep 30, 2019 | -157,317.46 |
| Sep 30, 2019 | -157,317.46 |
| Jun 30, 2019 | -581,430.50 |
| Jun 30, 2019 | -581,430.50 |
| Mar 31, 2019 | -1.28 Mn |
| Mar 31, 2019 | -1.28 Mn |
| Dec 31, 2018 | 1.47 Mn |
| Dec 31, 2018 | 1.47 Mn |
| Sep 30, 2018 | -1.59 Mn |
| Sep 30, 2018 | -1.59 Mn |
| Jun 30, 2018 | 963,125.30 |
| Jun 30, 2018 | 963,125.30 |
| Mar 31, 2018 | 20,033.72 |
| Mar 31, 2018 | 20,033.72 |
| Dec 31, 2017 | 2.63 Bn |
| Dec 31, 2017 | 2.63 Bn |
| Sep 30, 2017 | -2.70 Bn |
| Sep 30, 2017 | -2.70 Bn |